Francesca Rolla

Litigation partner at Hogan Lovells

[Hogan Lovells Cadwalader - Disputes @HLCDisputes]

Our @HLLifeSciences group have produced a Horizons report, with contributions from our @HlLitigation partners on the topics of #cyberattacks, IWCF developments, and the benefits and risks of #ArtificialIntelligence in the #LifeSciences industry. Click below for the full report. https://t.co/zycvuZoCtR

[Hogan Lovells - HL BaSE @HLBaSE]

Thanks to all applicants to HL BaSE Training! We've had some cracking candidates and wish we could offer everyone a place. We'll have an HL BaSE Catalyst workshop in April & HL BaSE Training running again in Sept, so keep following for more #SocEnt #HLProBono opps! 😀

[Cecile Derycke @CecileDerycke]

Well done to Natalia and her team: great win for branded products in Russia! https://t.co/n2ssq6N9cB

[Hogan Lovells Cadwalader - Disputes @HLCDisputes]

Product liability, safety and compliance. @HoganLovells partner Sebastian Polly sheds light on challenges that companies face when launching innovative products https://t.co/v1J4BIFUQU #productliability

[Hogan Lovells Cadwalader - Disputes @HLCDisputes]

About to initiate arbitral proceedings under multiple contracts? Check out the highly relevant case law update of @HoganLovells: The Devil is in the Detail"s" - A cautionary tale for Commencing Multi-Contract #Arbitrations https://t.co/UK9ndevdMF

[Matthias M Schweiger @mattmschweiger]

ICYMI: European Commission released GMP Guidelines for Investigational Medicinal Products https://t.co/t4JAl3e2qV

[Cecile Derycke @CecileDerycke]

5 years to join & hundreds of patients associations admissible: FR Parliament about to open wide the door to health-related class actions

[Francesca Rolla @RollaFrancesca]

#productsafety Seminar 22 October 2015 Recent developments on Product Safety and Market Surveillance.